Publication | Closed Access

Safety and immunogenicity of a novel multivalent OspA-based vaccine candidate against Lyme borreliosis: a randomised, phase 1 study in healthy adults

VaccinationVaccine DevelopmentVaccine ResearchMedicineImmunologyVaccine DesignPolyvalent VaccinePrecision VaccinologyLyme BorreliosisParasitologyTick-borne DiseaseHealthy Adults